Home » Topics » Disease categories and therapies » Dental

Dental
RSS

Snapshots of new dental research

March 14, 2006

A new synthetic polypeptide may have potential for tissue repair

Feb. 24, 2006

BioMimetic's GEM-21S approved for periodontal bone defects

Nov. 22, 2005

510(k) clearance for DynaGraft II in dental applications

Aug. 24, 2005

M-40403 alleviates periodontitis in rats

July 6, 2005

Acologix expands AC-100 phase II development for periodontal bone loss

May 30, 2005

Acologix advances AC-100 into phase II in dentistry

May 10, 2005

BioMimetic's GEM-21S recommended for approval

July 20, 2004

PMA for GEM-21S accepted for review

May 7, 2004

Enrollment under way in phase III Periostat MR study for adult periodontitis

April 13, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 12, 2025.
Deep Apple signs big Novo deal for cardiometabolic small molecules
BioWorld
Deep Apple Therapeutics Inc. could bring in as much as $812 million in a new collaboration and license deal with Novo Nordisk A/S. The total includes an...
23andme genetic privacy concerns garner Congressional scrutiny
BioWorld MedTech
The bankruptcy of genetic testing service 23andme Holding Corp. prompted a reaction from many quarters, but a June 11 Senate hearing highlighted an interest in...
3Sbio revs on with phase II data in tight PD-1/VEGF bispecific race
BioWorld
3Sbio Inc. reported interim phase II study results of its PD-1/VEGF bispecific antibody, SSGJ-707 – a “fabulous” asset, according to Pfizer Inc. CEO Albert...